“这不仅仅是运行测试”:操作员在澳大利亚实施分散式丙型肝炎即时检测项目的经验

IF 4.4 2区 医学 Q1 SUBSTANCE ABUSE
Grace K. Burton-McKeich , Lise Lafferty , Carla Treloar , Corey Markus , Susan Matthews , Tanya L. Applegate , Louise Causer , Jason Grebely , Alison D. Marshall
{"title":"“这不仅仅是运行测试”:操作员在澳大利亚实施分散式丙型肝炎即时检测项目的经验","authors":"Grace K. Burton-McKeich ,&nbsp;Lise Lafferty ,&nbsp;Carla Treloar ,&nbsp;Corey Markus ,&nbsp;Susan Matthews ,&nbsp;Tanya L. Applegate ,&nbsp;Louise Causer ,&nbsp;Jason Grebely ,&nbsp;Alison D. Marshall","doi":"10.1016/j.drugpo.2025.104800","DOIUrl":null,"url":null,"abstract":"<div><h3>Background</h3><div>The decentralisation of hepatitis C virus (HCV) point-of-care testing is a core part of Australia's strategy to meet WHO elimination targets. However, little is known about the experiences of providers implementing these interventions and thus what is needed to improve integration. The study aim was to understand operator experiences, including the challenges and enablers, of implementing point-of-care testing as part of a National Point-of-Care Testing Program.</div></div><div><h3>Methods</h3><div>Providers who were enrolled in the National Program and qualified to perform point-of-care testing were invited to participate in semi-structured qualitative interviews between April and August 2023. Data were analysed according to iterative categorisation and themes were organised according to Service delivery, Resources, and Governance—elements of the Health Systems Dynamics Framework.</div></div><div><h3>Results</h3><div>Of the 31 participants, most were from New South Wales (<em>n</em> = 17), were practicing clinicians (<em>n</em> = 18), worked in outpatient or community health clinics (<em>n</em> = 21), and had no previous experience using a molecular point-of-care testing device (<em>n</em> = 24). Many participants struggled to deliver HCV testing and treatment according to national HCV management guidelines. Some participants avoided using the point-of-care testing device altogether. Others found it challenging to manage the administrative load of delivering the National Program, including planning outreach and following-up clients. These challenges were exacerbated by workforce shortages, difficult-to-navigate IT systems, and a lack of specific implementation advice from Program leadership.</div></div><div><h3>Conclusions</h3><div>This study illustrates several challenges to and enablers of adopting a decentralised HCV point-of-care testing program, highlighting the need to further explore what providers require to effectively implement these interventions.</div></div>","PeriodicalId":48364,"journal":{"name":"International Journal of Drug Policy","volume":"140 ","pages":"Article 104800"},"PeriodicalIF":4.4000,"publicationDate":"2025-04-16","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"“It's not just running the test”: Operator experiences of implementing a decentralised hepatitis C point-of-care testing program in Australia\",\"authors\":\"Grace K. Burton-McKeich ,&nbsp;Lise Lafferty ,&nbsp;Carla Treloar ,&nbsp;Corey Markus ,&nbsp;Susan Matthews ,&nbsp;Tanya L. Applegate ,&nbsp;Louise Causer ,&nbsp;Jason Grebely ,&nbsp;Alison D. Marshall\",\"doi\":\"10.1016/j.drugpo.2025.104800\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<div><h3>Background</h3><div>The decentralisation of hepatitis C virus (HCV) point-of-care testing is a core part of Australia's strategy to meet WHO elimination targets. However, little is known about the experiences of providers implementing these interventions and thus what is needed to improve integration. The study aim was to understand operator experiences, including the challenges and enablers, of implementing point-of-care testing as part of a National Point-of-Care Testing Program.</div></div><div><h3>Methods</h3><div>Providers who were enrolled in the National Program and qualified to perform point-of-care testing were invited to participate in semi-structured qualitative interviews between April and August 2023. Data were analysed according to iterative categorisation and themes were organised according to Service delivery, Resources, and Governance—elements of the Health Systems Dynamics Framework.</div></div><div><h3>Results</h3><div>Of the 31 participants, most were from New South Wales (<em>n</em> = 17), were practicing clinicians (<em>n</em> = 18), worked in outpatient or community health clinics (<em>n</em> = 21), and had no previous experience using a molecular point-of-care testing device (<em>n</em> = 24). Many participants struggled to deliver HCV testing and treatment according to national HCV management guidelines. Some participants avoided using the point-of-care testing device altogether. Others found it challenging to manage the administrative load of delivering the National Program, including planning outreach and following-up clients. These challenges were exacerbated by workforce shortages, difficult-to-navigate IT systems, and a lack of specific implementation advice from Program leadership.</div></div><div><h3>Conclusions</h3><div>This study illustrates several challenges to and enablers of adopting a decentralised HCV point-of-care testing program, highlighting the need to further explore what providers require to effectively implement these interventions.</div></div>\",\"PeriodicalId\":48364,\"journal\":{\"name\":\"International Journal of Drug Policy\",\"volume\":\"140 \",\"pages\":\"Article 104800\"},\"PeriodicalIF\":4.4000,\"publicationDate\":\"2025-04-16\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"International Journal of Drug Policy\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://www.sciencedirect.com/science/article/pii/S0955395925000994\",\"RegionNum\":2,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q1\",\"JCRName\":\"SUBSTANCE ABUSE\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"International Journal of Drug Policy","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S0955395925000994","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"SUBSTANCE ABUSE","Score":null,"Total":0}
引用次数: 0

摘要

丙型肝炎病毒(HCV)护理点检测的分散化是澳大利亚实现世卫组织消除目标战略的核心部分。然而,人们对实施这些干预措施的提供者的经验知之甚少,因此也不知道需要什么来改善整合。研究的目的是了解运营商的经验,包括作为国家护理点测试计划的一部分实施护理点测试的挑战和推动因素。方法在2023年4月至8月期间,邀请参加国家计划并有资格进行即时护理测试的提供者参加半结构化定性访谈。根据迭代分类对数据进行分析,并根据卫生系统动力学框架的服务提供、资源和治理要素组织主题。结果在31名参与者中,大多数来自新南威尔士州(n = 17),是执业临床医生(n = 18),在门诊或社区卫生诊所工作(n = 21),并且以前没有使用分子点护理检测设备的经验(n = 24)。许多参与者努力按照国家HCV管理指南提供HCV检测和治疗。一些参与者完全避免使用即时检测设备。另一些人则认为,管理执行国家方案的行政负担很有挑战性,包括规划外展活动和跟踪客户。劳动力短缺、难以驾驭的IT系统以及缺乏来自项目领导的具体实施建议加剧了这些挑战。本研究阐明了采用分散式HCV即时检测方案的几个挑战和推动因素,强调了进一步探索提供者需要什么来有效实施这些干预措施的必要性。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
“It's not just running the test”: Operator experiences of implementing a decentralised hepatitis C point-of-care testing program in Australia

Background

The decentralisation of hepatitis C virus (HCV) point-of-care testing is a core part of Australia's strategy to meet WHO elimination targets. However, little is known about the experiences of providers implementing these interventions and thus what is needed to improve integration. The study aim was to understand operator experiences, including the challenges and enablers, of implementing point-of-care testing as part of a National Point-of-Care Testing Program.

Methods

Providers who were enrolled in the National Program and qualified to perform point-of-care testing were invited to participate in semi-structured qualitative interviews between April and August 2023. Data were analysed according to iterative categorisation and themes were organised according to Service delivery, Resources, and Governance—elements of the Health Systems Dynamics Framework.

Results

Of the 31 participants, most were from New South Wales (n = 17), were practicing clinicians (n = 18), worked in outpatient or community health clinics (n = 21), and had no previous experience using a molecular point-of-care testing device (n = 24). Many participants struggled to deliver HCV testing and treatment according to national HCV management guidelines. Some participants avoided using the point-of-care testing device altogether. Others found it challenging to manage the administrative load of delivering the National Program, including planning outreach and following-up clients. These challenges were exacerbated by workforce shortages, difficult-to-navigate IT systems, and a lack of specific implementation advice from Program leadership.

Conclusions

This study illustrates several challenges to and enablers of adopting a decentralised HCV point-of-care testing program, highlighting the need to further explore what providers require to effectively implement these interventions.
求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
CiteScore
7.80
自引率
11.40%
发文量
307
审稿时长
62 days
期刊介绍: The International Journal of Drug Policy provides a forum for the dissemination of current research, reviews, debate, and critical analysis on drug use and drug policy in a global context. It seeks to publish material on the social, political, legal, and health contexts of psychoactive substance use, both licit and illicit. The journal is particularly concerned to explore the effects of drug policy and practice on drug-using behaviour and its health and social consequences. It is the policy of the journal to represent a wide range of material on drug-related matters from around the world.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信